Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis

European Journal of Oral Sciences

Volumn 107, Issue 3, 1999, Pages 183-193

  Depondt, Joël ^a,b   Shabana, Al Hassan ^a,c   Florescu Zorila, Silvana ^a   Gehanno, Pierre ^b   Forest, Nadine ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Desmoplakin; Desmosome; Metastasis; Plakoglobin; Squamous cell carcinoma

Indexed keywords

CELL ADHESION MOLECULE; CYTOSKELETON PROTEIN; DESMOPLAKIN; DSP PROTEIN, HUMAN; PLAKOGLOBIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; DESMOSOME; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PHARYNX CANCER; PROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; ULTRASTRUCTURE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; DESMOPLAKINS; DESMOSOMES; DOWN-REGULATION; FEMALE; GAMMA CATENIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033142530     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1046/j.0909-8836.1999.eos1070305.x     Document Type: Article

References (49)

1. ERISEN L, BASUT O, TEZEL I, ONART S, ARAT M, HIZALAN I. Regional epidermological features of lip, oral cavity and oropharyngeal cancer. J Environ Pathol Toxicol Oncol 1996; 15: 225-229.
2. MACFARLANE GJ, EVSTIFEEVA TV, ROBERTSON C, BOYLE P, SCULLY C. Trends of oral cancer mortality among females worldwide. Cancer Causes Control 1994; 5: 255-258.
3. BONGERS V, BRAAKHUIS BJ, TOBI H, LUBSEN H, SNOW GB. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer. Cancer Epidemiol Biomarkers Prev 1996; 5: 595-598.
4. CHEN SY, HARWICK RD. Ultrastructure of oral squamous cell carcinoma. Oral Surg 1977; 44: 744-753.
5. KOUKLIS PD, HUTTON E, FUCHS E. Making a connexion: Direct binding between keratin intermediate filaments and desmosomal proteins. J Cell Biol 1994; 127: 1049-1060.
6. KOWALCZYK AP, STAPPENBACK TS, PARRY DAD, PALKA HL, VIRATA MLA, BORNSLAEGER EA, NILLES LA, GREEN KJ. Structure and function of desmosomal transmembrane core and plaque molecules. Biophys Chem 1994; 50: 97-112.
7. BUXTON RS, COWIN B, FRANKE WW, GARROD DR, GREEN KJ, KING IA, KOCH PJ, MAGEE AI, REES DA, STANLEY JR, STEINBERG MS. Nomenclature of desmosomal cadherins. J Cell Biol 1993; 121: 481-483.
8. SCHWARZ MA, OWARIBE K, KARTENBECK J, FRANKE WW. Desmosomes and hemidesmosomes : Constitutive molecular components. Ann Rev Cell Biol 1990; 6: 461-491.
9. BIRCHMEIER W, HüLSKEN J, BEHRENS J. Adherens junction proteins in tumour progression. Cancer Surv 1995; 24: 124-140.
10. MOLL R, COWIN P, KAPRELL HP, FRANKE WW. Desmosomal proteins: New markers for identification and classification of tumours. Lab Invest 1986; 54: 4-25.
11. ALROY J, PAULI BU, WEINSTEIN RS. Correlation between numbers of desmosmes and agressiveness of transitional cell carcinoma in human urinary bladder. Cancer 1981; 47: 104-112.
12. SCHINDLER AM, AMAUDRUZ MI, KOCHER O, RIOTTEN G, GABBIANI G. Desmosomes and gap junctions in various epidermoid preneoplastic and neoplastic lesions of the cervix uteri. Acta Cytol 1981; 26: 466-470.
13. OSBORN M, WEBER K. A monoclonal antibody recognizing desmosomes: Use in human pathology. J Invest Dermatol 1985; 85: 385-388.
14. VILELA MJ, PARRISH EP, WHIGHT DH, GARROD DR. Monoclonal antibody to desmosomal glycoprotein 1. A new epithelial marker for diagnostic pathology. J Pathol 1987; 153: 375-375.
15. CONN IG, VILELA MJ, GARROD DR, CROCKER G, WALLACE DMA. Immunohistochemical staining with monoclonal antibody 32-2B to desmosomal glycoprotein 1. Its role in the histological assessment of urothelial carcinomas. Br J Urol 1990; 65: 176-180.
16. COLLINS JE, TAYLOR I, GARROD DR. A study of desmosomes in colorectal carcinoma. Br J Cancer 1990; 62: 796-805.
17. GARROD DR. Desmosomes and cancer. Cancer Surv 1995; 24: 97-111.
18. HARADA T, SHINOHARA M, NAKAMURA N, SHIMADA M, OKA M. Immunohistochemical detection of desmosomes in oral squamous cell carcinoma: Correlation with differentiation, mode of invasion and metastatic potential. Int J Oral Maxillofac Surg 1992; 21: 346-349.
19. SHINOHARA M, HIRAKI A, IKEBE T, NAKAMURA S, KURAHARA S, SHIRASUNA K, GARROD DR. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J Pathol 1998; 184: 369-381.
20. KRUNIC AL, GARROD DR, MADANI S, BUCHANAN MD, CLARK RE. Immunohistochemical staining for desmogleins 1 and 2 in keratocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Br J Cancer 1998; 8: 1275-1279.
21. KRUNIC AL, GARROD DR, SMITH NP, ORCHARD GS, CVIJETIC OB. Differtential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin: an immunohistochemical aid to diagnosis. Acta Derm Venereol 1996; 5: 394-398.
22. NATSUGOE S, MUELLER J, KIJIMA F, ARIDOME K, SHIMADA M, SHIRAO K, KUSANO C, BABA M, YOSHINAKA H, FUKUMOTO T, AIKOU T. Extranodal connective tissue invasion and the expression of desmosomal glycoprotein 1 in squamous cell carcinoma of the oesophagus. Br J Cancer 1997; 6: 892-897.
23. KARNOFSKY DA. Determining the extent of the cancer and clinical planning for cure. Cancer 1968; 22: 730-734.
24. Histological typing of oral and oropharyngeal tumours. Geneva: World Health Organization, 1971.
25. HERMANEK P, SOBIN LH. UICC. TNM classification of malignant tumours, 4th edition. Berlin: Springer Verlag, 1987.
26. SHABANA AHM, OUHAYOUN JP, SAWAF MH, FOREST N. Cytokeratin patterns of human oral mucosae in histiotypic culture. Arch Oral Biol 1991; 36: 747-758.
27. ACHTÄSTATTER T, MOLL R, MOORE B, FRANKE WW. Cytokeratin polypeptide patterns of different epithelia of human male urogenital tract: Immunofluorescence and gel electrophoresis studies. J Histochem Cytochem 1985; 33: 415-426.
28. O'FARRELL PZ, GOODMAN HM, O'FARRELL PH. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 1977; 12: 1133-1142.
29. LAEMMLI UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
30. HIRAKI A, SHINOHARA M, IKEBE T, NAKAMURA N, KURAHARA S, GARROD DR. Immunohistochemical staining of desmosomal components in oral squamous cell carcinomas and its association with tumour behaviour. Br J Cancer 1996; 73: 1491-1497.
31. GARROD DR. Desmosomes and hemidesmosomes. Curr Op Cell Biol 1993; 5: 30-40.
32. STAPPENBECK TS, GREEN KJ. The desmoplakin carboxyl terminus coaligns with and specifically disrupts intermediate filament networks when expressed in cultured cells. J Cell Biol 1992; 116: 1197-1209.
33. TAKEICHI M. Cadherin cell adhesion receptors as a morphologic regulator. Science 1991; 251: 1451-1455.
34. GHADIALLY FN. Ultrastructural pathology of the cell and matrix. In: A text and atlas of physiological and pathological alterations in the fine structure of cellular and extracellular components, 3rd edition. Vol. II. London: Butterworths, 1988; 1006-1009.
35. KANAME H, YOSAHIHARA T, YAKU Y, ISHII T. Ultrastructure of primary squamous cell carcinoma of the submandibular gland. Med Electron Microsc 1993; 26: 99-104.
36. SHABANA AHM, AMAR L, OBOEUF M, MARTIN N, FOREST N. Induction of cytoplasmic desmosome assembly by H-7 treatment in cultured fetal rat keratinocytes. Tissue Cell 1996; 28: 537-545.
37. TAKENAGA K, TAKAHASKI K. Effects of 12-O-tetradecanoyl-phorbol-13-acetate on adhesiveness and lung-colonizing ability of Lewis lung carcinoma cells. Cancer Res 1986; 46: 375-380.
38. SCHIPPER JH, FRIXEN UH, BEHRENS J, UNGER A, JAHNKE K, BIRCHMEIER W. E-cadherin expression in squamous cell carcinomas of head and neck: Inverse correlation with tumour dedifferentiation and lymph node metastasis. Cancer Res 1991; 51: 6328-6337.
39. HATZFELD M, NACHTSHEIM C. Cloning and characterization of a new armadillo family member, P0071 associated with the junctional plaque: Evidence for a subfamily of closely related proteins. J Cell Sci 1996; 109: 2767-2778.
40. BIERKAMP C, MCLAUGHLIN KJ, SCHWARZ H, HUBER O, KEMLER R. Embryonic heart and skin defects in mice lacking plakoglobin. Develop Biol 1996; 180: 780-785.
41. SIMCHA I, GEIGER B, YEHUDA-LEVENBERG S, SALOMON D, BEN ZE'EV A. Suppression of tumourigenicity by plakoglobin: An augmenting effect of N-cadherin. J Cell Biol 1996; 133: 199-209.
42. BEN-ZE'EV A. Cytoskeletal and adhesion proteins as tumour suppressors. Curr Op Cell Biol 1977; 9: 99-108.
43. ABERLE H, BIERKAMP C, TORCHARD D, SEROVA O, WAGENER T, NATT E, WIRSCHING J, HEIDKäMPER C, MONTAGNA M. The human plakoglobin gene localizes on chromosome 17q21 and is subject to loss of heterozygosity in breast and ovarian cancer. Proc Natl Acad Sci USA 1995; 92: 6384-6388.
44. SOMMERS CL, GELMANN EP, KEMLER R, COWIN P, BYERS SW. Alterations in β-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 1994; 54: 3544-3552.
45. NAVARRO P, LOZANO E, CANO A. Expression of E- or P-cadherin is not sufficient to modify the morphology and the tumourigenic behavior of murine spindle carcinoma cells. J Cell Sci 1993; 105: 923-934.
46. VIKRAM B, STRONG EW, SHAH JP, SPIRO R. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984; 6: 730-733.
47. TSUJINO K, OSHITANI T, KUSHIMA T, MIEDA C, HIROTA S, OGAWA K, MARUTA T, IKEDA Y, UEDA E, SUEMATSU T. Clinical results of NO tongue cancer treated with interstitial brachytherapy and management of occult cervical node metastases. Nippon Igaku Hoshasen Gakkai Zasshi 1991; 51: 671-677.
48. SLOTMAN GJ, MOHIT T, RAINA S, SWAMINATHAN AP, OHANIAN M, RUSH BF-JR. The incidence of metastases after multimodal therapy for cancer of the head and neck. Cancer 1984; 54: 2009-2014.
49. LARAMORE GE, SCOTT CB, AL-SARRAF M, HASELOW RE, ERVIN TJ. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study 0034. Int J Radiation Oncology Biol Phys 1992; 23: 705-713.